Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Pregnancy and post-partum breast cancer: a prospective study.

Mathelin C, Annane K, Treisser A, Chenard MP, Tomasetto C, Bellocq JP, Rio MC.

Anticancer Res. 2008 Jul-Aug;28(4C):2447-52.

2.

Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study.

Halaska MJ, Pentheroudakis G, Strnad P, Stankusova H, Chod J, Robova H, Petruzelka L, Rob L, Pavlidis N.

Breast J. 2009 Sep-Oct;15(5):461-7. doi: 10.1111/j.1524-4741.2009.00760.x. Epub 2009 Jun 13.

PMID:
19624421
3.

Clinicopathological features and prognosis of pregnancy associated breast cancer - a matched case control study.

Madaras L, Kovács KA, Szász AM, Kenessey I, Tőkés AM, Székely B, Baranyák Z, Kiss O, Dank M, Kulka J.

Pathol Oncol Res. 2014 Jul;20(3):581-90. doi: 10.1007/s12253-013-9735-9. Epub 2013 Dec 20.

PMID:
24357159
4.

[Pregnancy-Associated Breast Cancer: An analytical observational study].

Baulies S, Cusidó M, Tresserra F, Rodríguez I, Ubeda B, Ara C, Fábregas R.

Med Clin (Barc). 2014 Mar 4;142(5):200-4. doi: 10.1016/j.medcli.2012.12.020. Epub 2013 Mar 13. Spanish.

PMID:
23490493
5.

Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.

Azim HA Jr, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameye L, De Mattos-Arruda L, Pistilli B, Pinto A, Jensen MB, Cordoba O, de Azambuja E, Goldhirsch A, Piccart MJ, Peccatori FA.

J Clin Oncol. 2013 Jan 1;31(1):73-9. doi: 10.1200/JCO.2012.44.2285. Epub 2012 Nov 19.

6.

Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer.

Murphy CG, Mallam D, Stein S, Patil S, Howard J, Sklarin N, Hudis CA, Gemignani ML, Seidman AD.

Cancer. 2012 Jul 1;118(13):3254-9. doi: 10.1002/cncr.26654. Epub 2011 Nov 15.

7.

Survival outcomes in pregnancy associated breast cancer: a retrospective case control study.

Ali SA, Gupta S, Sehgal R, Vogel V.

Breast J. 2012 Mar-Apr;18(2):139-44. doi: 10.1111/j.1524-4741.2011.01201.x. Epub 2012 Feb 23.

PMID:
22356297
8.

[Treatment of pregnancy associated breast cancer].

Székely B, Langmár Z, Somlai K, Szentmártoni G, Szalay K, Korompay A, Szász AM, Kulka J, Bánhidy F, Dank M.

Orv Hetil. 2010 Aug 8;151(32):1299-303. doi: 10.1556/OH.2010.28886. Hungarian.

PMID:
20656670
9.

Multidisciplinary management of breast cancer concurrent with pregnancy.

Keleher AJ, Theriault RL, Gwyn KM, Hunt KK, Stelling CB, Singletary SE, Ames FC, Buchholz TA, Sahin AA, Kuerer HM.

J Am Coll Surg. 2002 Jan;194(1):54-64. Review.

PMID:
11800340
10.

Expression of pS2 protein and estrogen and progesterone receptor status in breast cancer.

Ioakim-Liossi A, Karakitsos P, Markopoulos C, Aroni K, Delivelioti K, Gogas J, Kyrkou K.

Acta Cytol. 1997 May-Jun;41(3):713-6.

PMID:
9167689
11.

Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer.

Tong D, Schneeberger C, Czerwenka K, Schmutzler RK, Speiser P, Kucera E, Concin N, Kubista E, Leodolter S, Zeillinger R.

Clin Cancer Res. 1999 Jun;5(6):1497-502.

12.

Pregnancy associated breast cancer.

Makgasa M, Prichard RS, Malone C, Kerin MJ.

Ir Med J. 2009 Nov-Dec;102(10):314-7.

PMID:
20108797
14.

Evaluation of ER, PR, MIB-1, pS2, and nuclear grade in FNA specimens of cT1 breast carcinomas: clinicopathological correlation.

Angelidou E, Politi E, Sotiropoulou G, Poulianou E, Koutselini H.

Diagn Cytopathol. 2006 Aug;34(8):547-52.

PMID:
16850494
15.

Cytosolic levels of TFF1/pS2 in breast cancer: Their relationship with clinical-pathological parameters and their prognostic significance.

Corte MD, Tamargo F, Alvarez A, Rodríguez JC, Vázquez J, Sánchez R, Lamelas ML, González LO, Allende MT, García-Muñiz JL, Fueyo A, Vizoso F.

Breast Cancer Res Treat. 2006 Mar;96(1):63-72. Epub 2005 Nov 3.

PMID:
16267614
16.

Preliminary monocentric results of biological characteristics of pregnancy associated breast cancer.

Michieletto S, Saibene T, Evangelista L, Barbazza F, Grigoletto R, Rossi G, Ghiotto C, Bozza F.

Breast. 2014 Feb;23(1):19-25. doi: 10.1016/j.breast.2013.10.001. Epub 2013 Nov 1.

PMID:
24189101
17.

Pregnancy associated breast cancer: an institutional experience.

Gogia A, Deo SV, Shukla NK, Mohanti BK, Raina V.

Indian J Cancer. 2014 Apr-Jun;51(2):167-9. doi: 10.4103/0019-509X.138285.

18.

Risk factors for pregnancy-associated breast cancer: a report from the Nigerian Breast Cancer Study.

Hou N, Ogundiran T, Ojengbede O, Morhason-Bello I, Zheng Y, Fackenthal J, Adebamowo C, Anetor I, Akinleye S, Olopade OI, Huo D.

Ann Epidemiol. 2013 Sep;23(9):551-7. doi: 10.1016/j.annepidem.2013.06.008. Epub 2013 Jul 20.

19.

Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis.

Strasser-Weippl K, Ramchandani R, Fan L, Li J, Hurlbert M, Finkelstein D, Shao ZM, Goss PE.

Breast Cancer Res Treat. 2015 Jan;149(1):255-61. doi: 10.1007/s10549-014-3219-9. Epub 2014 Dec 14.

PMID:
25504083
20.

Cytosolic levels of an estrogen-induced breast cancer-associated peptide (TFF1/pS2) in colorectal cancer: clinical significance and relationship with steroid receptors.

Vizoso FJ, Fagilde MC, Corte MD, Corte MG, Gava R, Bongera M, Allende MT, García-Muñiz JL.

Int J Biol Markers. 2003 Oct-Dec;18(4):301-10.

PMID:
14756547

Supplemental Content

Support Center